SCHEMBL11252258

SCHEMBL11252258

CC1CC(=O)N(c2ccncc2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.47
ALDH1A1 P00352 8/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
BCHE P06276 1/20 0.46
MAPT P10636 2/20 0.45
GAA P10253 1/20 0.45
ALOX12 P18054 1/20 0.45
LMNA P02545 1/20 0.44
NPSR1 Q6W5P4 1/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16566170 0.87 ALDH1A1 (0.50) ALDH1A1MAPTGAAALOX12LMNA
SCHEMBL3485977 0.81 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2MAPTGAALMNA
SCHEMBL774049 0.81 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2MAPTGAALMNA
SCHEMBL28243691 0.81 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2MAPTGAALMNA
SCHEMBL14821834 0.80 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL20375597 0.79 MAPT (0.42) ALDH1A1SMN1; SMN2HSD17B10MAPTLMNA
SCHEMBL13478303 0.79 L3MBTL1 (0.47) ALDH1A1MAPTGAAALOX12LMNA
SCHEMBL13057567 0.79 ALDH1A1 (0.51) ALDH1A1KMT2AMAPTGAAALOX12
SCHEMBL16450893 0.79 HSP90AA1 (0.59) USP2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6545138 0.79 ALDH1A1 (0.41) ALDH1A1MAPTGAAALOX12LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4309541-A CHEMICAL INTERMEDIATES TO QUINAZOLINE HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1982-01-05 US disclosed
US-4255429-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1981-03-10 US disclosed
EP-0009465-A1 N-(1-(4-amino-2-quinazolinyl)-3 or 4-piperidyl lactames, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1980-04-02 EP disclosed